Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tollman

Showing results (161-170 of 193) with videos related to

Pageof 20
Sort By:
Emerging Infectious Diseases|March 23, 2022
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South AfricaJackie Kleynhans, Stefano Tempia, Nicole Wolter, et al.
The Lancet. HIV|September 2, 2022
A community mobilisation intervention to improve engagement in HIV testing, linkage to care, and retention in care in South Africa: a cluster-randomised controlled trialSheri A Lippman, Audrey Pettifor, Mi-Suk Kang Dufour, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Participant engagement and feedback in microbiome projects: a case of AWI-Gen 2Claudine Nkera-Gutabara, Luicer A Ingasia Olubayo, Ovokeraye O Oduaran, et al.
BMC Infectious Diseases|March 22, 2024
Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
JMIR Public Health and Surveillance|April 7, 2021
Protective Behaviors and Secondary Harms Resulting From Nonpharmaceutical Interventions During the COVID-19 Epidemic in South Africa: Multisite, Prospective Longitudinal StudyGuy Harling, Francesc Xavier Gómez-Olivé, Joseph Tlouyamma, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Protective behaviours and secondary harms from non-pharmaceutical interventions during the COVID-19 epidemic in South Africa: a multisite prospective longitudinal studyGuy Harling, Francesc Xavier Gómez-Olivé, Joseph Tlouyamma, et al.
American Journal of Epidemiology|November 1, 2019
Depression and Incident HIV in Adolescent Girls and Young Women in HIV Prevention Trials Network 068: Targets for Prevention and Mediating FactorsDana E Goin, Rebecca M Pearson, Michelle G Craske, et al.
Science Translational Medicine|May 31, 2022
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron's impact in South African population cohortsKaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
The Lancet. Infectious Diseases|March 17, 2022
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
Pageof 20

Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
Emerging Infectious Diseases|March 23, 2022
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South AfricaJackie Kleynhans, Stefano Tempia, Nicole Wolter, et al.
The Lancet. HIV|September 2, 2022
A community mobilisation intervention to improve engagement in HIV testing, linkage to care, and retention in care in South Africa: a cluster-randomised controlled trialSheri A Lippman, Audrey Pettifor, Mi-Suk Kang Dufour, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Participant engagement and feedback in microbiome projects: a case of AWI-Gen 2Claudine Nkera-Gutabara, Luicer A Ingasia Olubayo, Ovokeraye O Oduaran, et al.
BMC Infectious Diseases|March 22, 2024
Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
JMIR Public Health and Surveillance|April 7, 2021
Protective Behaviors and Secondary Harms Resulting From Nonpharmaceutical Interventions During the COVID-19 Epidemic in South Africa: Multisite, Prospective Longitudinal StudyGuy Harling, Francesc Xavier Gómez-Olivé, Joseph Tlouyamma, et al.
Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Protective behaviours and secondary harms from non-pharmaceutical interventions during the COVID-19 epidemic in South Africa: a multisite prospective longitudinal studyGuy Harling, Francesc Xavier Gómez-Olivé, Joseph Tlouyamma, et al.
American Journal of Epidemiology|November 1, 2019
Depression and Incident HIV in Adolescent Girls and Young Women in HIV Prevention Trials Network 068: Targets for Prevention and Mediating FactorsDana E Goin, Rebecca M Pearson, Michelle G Craske, et al.
Science Translational Medicine|May 31, 2022
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron's impact in South African population cohortsKaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
The Lancet. Infectious Diseases|March 17, 2022
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
Pageof 20